Financial Data and Key Metrics Changes - PetVivo reported a record revenue of $1.1 million for fiscal year 2025, reflecting a 17% increase compared to the previous year [4][7] - Gross profit totaled $995,000, representing a gross margin of 87.8%, which is a slight decrease from 89.5% in fiscal year 2024 [8] - Operating expenses decreased by 21% to $9.1 million, primarily due to a strategic cost reduction program [8] - The net loss improved by 27% to $8 million, or $0.39 per share, compared to a net loss of $11 million, or $0.78 per share in fiscal year 2024 [9] Business Line Data and Key Metrics Changes - The expanding nationwide distributor network contributed $958,000 in sales, accounting for 86% of total revenues, with a 31% increase in their combined sales [7][8] - The company is focusing on increasing its market share in the companion animal segment while maintaining growth in the equine market [4][5] Market Data and Key Metrics Changes - The veterinary healthcare market in Mexico is projected to grow at a 6% CAGR, reaching nearly $2 billion by 2026, presenting a significant opportunity for PetVivo [3] - The U.S. animal health market is projected to double to $11.3 billion by 2030, providing substantial growth potential for the company [18] Company Strategy and Development Direction - The company aims to drive greater adoption of its products, particularly Spring and Precise PRP, by increasing awareness among key decision-makers in the veterinary field [11][12] - Strategic partnerships and collaborations, such as with Digital Landia and Commonwealth Markets, are expected to enhance product visibility and market penetration [16][24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong sales momentum and market penetration expected in fiscal year 2026 [17] - The company is well-positioned to accelerate growth and expand into high-growth markets, driven by trends in pet ownership and advancements in veterinary care [18][19] Other Important Information - The company filed for an extension for its Form 10-K filing to allow auditors to complete their review, meaning all financial results presented are preliminary and unaudited [2][7] - The company raised net proceeds of $4.7 million from a Series B convertible preferred stock offering to support growth strategies [10] Q&A Session Summary Question: How much dilution do you expect from the conversion of the Series B preferred? - Management indicated that the conversion is on a one-to-one basis, with an additional 5 million shares expected if fully converted [30][32] Question: What is the average price per vial of the Spring injection that veterinarians are charging for canines? - The average charge by veterinary doctors is around $800 per joint, with variations between $500 to $1,200 depending on the complexity of the issue [36] Question: Can you talk a little bit about the human trials and their projected outcomes? - Management discussed ongoing studies with BioPiezo, showing promising results in small and large animals, with potential applications in the human market for osteoarthritis [46]

quote utterly insane and destructive. Quote, "An unhappy episode." The reviews are in, and even Republicans and their allies are warning about the consequences of Trump's so-called big beautiful bill. At this hour, the Senate is in the middle of a marathon voting session, taking up amendments to the bill from members of both parties.The goal to pass the bill later today. And rarely, if ever, have members of a political party seemed so glum on the eve of passing major legislation. With Democrats unified in t ...

Nearly half (47%) of U.S. workers have experienced career gaps, according to a recent MyPerfectResume report. Yet, countless talented professionals sabotage their job search by treating a career gap like a dirty secret. https://t.co/pHE79Dmq3V https://t.co/cihgnnMtaI ...

Core Insights - Amazon's entry into healthcare has significantly disrupted the traditional pharmacy landscape, raising concerns for established players like CVS Health [1][3] - CVS Health is rebounding strongly in 2025, becoming one of the top performers in the S&P 500, with a focus on integrated care and leveraging its extensive physical presence [2][10] Group 1: Company Strategies - Amazon is leveraging its logistics capabilities and technology to redefine healthcare delivery, including AI-powered prescription fulfillment and at-home diagnostics [1][5][7] - CVS Health is capitalizing on its vast network of over 9,000 retail pharmacies and integrated services to provide coordinated care and improve patient outcomes [4][6] Group 2: Performance Metrics - CVS Health reported $95 billion in revenue in Q1 2025 and has achieved a year-to-date stock performance of 56%, ranking eighth in the S&P 500 [2][10] - In contrast, Amazon's stock has only risen by 1.8% year-to-date, placing it at number 262 in the S&P 500 rankings [10][9] Group 3: Financial Projections - The Zacks Consensus Estimate for CVS's 2025 earnings per share suggests a 12.7% improvement from 2024, indicating strong growth potential [12] - Amazon's 2025 EPS is projected to improve by 12.5% over the previous fiscal year, reflecting ongoing growth in its healthcare initiatives [14] Group 4: Valuation Comparisons - CVS is trading at a forward price-to-earnings ratio of 10.48X, which is above its five-year median, yet remains attractively valued compared to Amazon's 33.3X [15] - Amazon's current valuation is below its five-year median, suggesting potential for future growth but also indicating higher execution risk in its healthcare ventures [15][16]

OR CALL NOW. >> THE MARATHON ON THE HILL CONTINUES, AND WE DON'T KNOW EXACTLY WHEN THE SENATE WILL FINALLY HAVE A FINAL ANSWER ON THE BUDGET BILL CRITICAL TO DONALD TRUMP AND HIS VISION FOR HIS SECOND TERM, OR WHAT IT WILL BE. I WANT TO BRING IN SAHIL KAPUR, WHO IS ON CAPITOL HILL FOR US.SAHIL, WHAT SHOULD WE BE WATCHING FOR. WHAT ARE YOU WATCHING FOR RIGHT NOW. >> CHRIS, WE ARE A FEW.>> HOURS INTO THIS SO-CALLED VOTE A RAMA PROCESS. THE BIG THING I'M WATCHING FOR IS THESE AMENDMENTS THAT ARE COMING UP. HOW ...

It's been a long debate. I know people are weary, but at the end of the day, we want to get this done so this country is safer and stronger and more prosperous. [Music] The Medicaid proposal in this bill bears no resemblance to that kind of discipline and due diligence.It has no insights into how these provider tax cuts are going to be absorbed without harming people on Medicare. We're going to make sure that we fulfill the promise and then we can feel I can feel good about a bill that I'm willing to vote f ...

The Supreme Court ended its term on June 27th and we saw a number of key decisions. Our readers had some questions. Here are a few of them.Paul asks, "I am not clear on what the ruling on injunctions means. Does this not allow a president to create laws, limit rights, and impose measures unilaterally, giving the president dictatorial powers?" So certainly the court is giving the president wider discretion to act and making it more difficult for judges to limit the president's actions. That said, the preside ...

In President Trump's controversial spending bill, there are few things more controversial, including within his own party as how it changes the way states receive Medicaid funds and instead creates a $25 billion fund to support rural hospitals. Critics say that is not enough and will cost lives. So, what can Democrats do about it.Joining me now is Democratic Senator Ed Marky of Massachusetts. It's good to see you, Senator. And you and your Democratic colleagues have pointed this out that Republican healthc ...

Core Viewpoint - Equasens Group has completed the acquisition of two businesses specializing in software solutions for the public healthcare sector, enhancing its position in the hospital and medico-social software market [3][4][10] Acquisition Details - The acquisition was finalized on July 1, 2025, through the AXIGATE LINK Division, covering over 300 customers in the public healthcare sector and generating annual sales of approximately €5 million [3][5][7] - The acquired businesses include the ResUrgences software platform, which manages hospital emergency services, and the DIS range, which provides digital solutions for public healthcare establishments [8][10] Strategic Goals - This acquisition aligns with Equasens' strategy to develop software solutions for public health establishments, capitalizing on numerous renewal and equipment opportunities in the market [6][10] - The integration aims to create a comprehensive technology ecosystem to support the digital transformation of both public and private healthcare establishments [4][10] Product and Service Expansion - The AXIGATE LINK Division will enhance its HOSPILINK solution for hospitals and specialized facilities, optimizing resources and accelerating innovation through technical and commercial synergies [5][9][10] - The short-term objective includes integrating new functionalities from the acquisition into existing product ranges, while the medium-term goal focuses on improving interoperability across various healthcare services [12][13] Leadership Commentary - The CEO of Equasens emphasized the acquisition's role in expanding and diversifying the company's core business, aiming to meet the growing digital needs of healthcare establishments [14] - The Deputy CEO highlighted the acquisition's significance in strengthening the company's presence in the public health sector, enhancing market share, expertise, and product range [14] Integration Timeline - Operational integration of the teams and solutions is set to begin in Q3 2025, with a phased migration plan for customers to Equasens' new technology platforms [15]

Joining us now, former Democratic Congresswoman Donna Edwards from Maryland and former Republican Congressman Carlos Carbelloo from Florida. Donna and Carlos, both MSNBC political analysts. We're grateful for both of you.Donna, what are the types of amendments that we might see in this voter during this marathon in the next few hours. Well, I think if you look, there are a whole range of amendments that are designed to bring certain senators along. um you know provisions for example for rural health care um ...